Peter Madrid

About

Peter Madrid is the Head of Scientific Development at Synfini, Inc., located in the United States. His research focuses on computational chemistry and antiviral therapies, as evidenced by his recent publications on topics such as retrosynthetic planning software and machine learning models for predicting molecular properties. Additionally, he has explored repurposing compounds for treating Ebola virus disease, showcasing his commitment to addressing emerging viral threats.